Raipur. To provide relief to patients undergoing cancer treatment, the Central Government has revised the prices of 137 anti-cancer drugs. The National Pharmaceutical Pricing Authority (NPPA) has implemented ‘Trade Margin Rationalization’ (TMR) for these 137 non-scheduled anti-cancer drugs. Consequently, the revised Maximum Retail Price (MRP) for these medicines has come into effect as of November 9, 2026.
In Chhattisgarh, the Chhattisgarh Pharmaceutical and Medical Devices Regulatory Authority (CGPMRU) has issued necessary directives to pharmacists, hospitals, and medical institutions to ensure that patients benefit from these new prices. The directives mandate adherence to the revised MRP, the display of price lists for medicines, and a strict prohibition against charging more than the prescribed price.
Check the MRP before purchasing medicines
The CGPMRU has urged cancer patients and the general public to verify the Maximum Retail Price (MRP) printed on the packaging when purchasing medicines. If any pharmacist demands a price higher than the prescribed rate or refuses to supply the medicine, a complaint can be filed via the designated helpline numbers or email addresses.
File complaints through these numbers and email addresses
NPPA Helpline: 1800-111-255
CGPMRU Helpline: 9340595097
CGPMRU Email: cg-pmru@cg.gov.in
NPPA Email: monitoring-nppa@gov.in
A notification issued by the Office of the Controller, Food and Drug Administration, Chhattisgarh, encourages patients to take advantage of these revised prices. Furthermore, it advises patients to immediately lodge a complaint if they are charged more than the prescribed price for any medicine.
